Rethinking screening for breast cancer and prostate cancer.

@article{Esserman2009RethinkingSF,
  title={Rethinking screening for breast cancer and prostate cancer.},
  author={L. Esserman and Yiwey Shieh and I. Thompson},
  journal={JAMA},
  year={2009},
  volume={302 15},
  pages={
          1685-92
        }
}
After 20 years of screening for breast and prostate cancer, several observations can be made. First, the incidence of these cancers increased after the introduction of screening but has never returned to prescreening levels. Second, the increase in the relative fraction of early stage cancers has increased. Third, the incidence of regional cancers has not decreased at a commensurate rate. One possible explanation is that screening may be increasing the burden of low-risk cancers without… Expand
Prostate Cancer Screening
Screening for pancreatic cancer.
Cancer overdiagnosis: a biological challenge and clinical dilemma
Population-based screening for cancer: hope and hype
Breast cancer screening.
  • P. Autier
  • Medicine
  • European journal of cancer
  • 2011
Mammography screening: A major issue in medicine.
Effect of three decades of screening mammography on breast-cancer incidence.
Screening for breast and prostate cancers: moving toward transparency.
  • D. Newman
  • Medicine
  • Journal of the National Cancer Institute
  • 2010
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 90 REFERENCES
Active surveillance for prostate cancer.
Mortality results from a randomized prostate-cancer screening trial.
Computed Tomography Screening and Lung Cancer Outcomes
Evaluation of the effect of screening on the detection of good and poor prognosis breast cancers.
Effect of screening and adjuvant therapy on mortality from breast cancer
...
1
2
3
4
5
...